Skip to content
Disclosery

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: MD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP on MD, newest first. How the timeline and the estimate are built.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP held 0 MD shares at 2026-03-31 per its 13F-HR filed 2026-05-14.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -192,527 shares

    13F-HR 0001164508-26-000028 filed by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 192,527 shares
    Change vs previous 13F +23,241 shares

    <0.01% of the 13F portfolio, value $4,118,153.

    13F-HR 0001164508-26-000002 filed by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 169,286 shares
    Change vs previous 13F -31,619 shares

    <0.01% of the 13F portfolio, value $2,835,541.

    13F-HR 0001164508-25-000009 filed by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 200,905 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $2,882,987.

    13F-HR 0001402828-25-000008 filed by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).